
CASES · 6 MONTHS
11,200+
DEATHS
5,500+
PLEDGED FUNDS MISSING
55%
CASE FATALITY RATE
~50%
Six months after the Democratic Republic of the Congo declared an Ebola outbreak caused by the rare Bundibugyo strain, Africa CDC Director-General Jean Kaseya says it remains "still not under control" and warns it could surpass every previous Ebola outbreak in scale. The numbers already place it as the second-largest on record: more than 11,200 confirmed cases and 5,500 deaths across eight of the DRC's 26 provinces, with cases now reported in East, Central, and West Africa — the widest geographic spread of any Ebola outbreak on the continent.
Extraction Map
The containment architecture is failing at every layer. Eighty percent of new cases emerge outside contact lists, meaning surveillance networks are missing the vast majority of transmission chains. Over 65 percent of deaths occur in the community rather than in treatment centres, which means both that patients aren't reaching care and that unsafe burials are likely seeding further transmission. Delayed detection, active conflict zones, and strained health services have compounded the speed of spread beyond what previous outbreaks produced. The funding picture is stark. Donors pledged $2.9 billion to fight the outbreak. Only $1.3 billion has actually been released — a 55 percent shortfall. Kaseya called the coordination between the DRC government and international donors "a collective failure," noting that health workers on the front line "hadn't been paid for months." The DRC is now working to digitise payroll systems to reduce duplication and waste, but that is an administrative fix applied to a crisis already six months deep. The biological challenge is severe. No vaccine or treatment exists specifically for the Bundibugyo strain, which kills roughly half the people it infects. The WHO has approved clinical trials of two new Ebola vaccines, with results expected in early 2027 — meaning even an optimistic timeline leaves months of unprotected transmission ahead. WHO Director-General Tedros Adhanom Ghebreyesus noted that transmission is slowing in some early epicentres and that at least 3,000 people have recovered, but these are encouraging signals inside a fundamentally uncontrolled outbreak. The structural problem is legible: a rare pathogen with no targeted countermeasure, spreading in a conflict-affected country with weak health infrastructure, funded by a donor system that has released barely half its commitments. Each of these failures reinforces the others. Without contact tracing coverage, cases multiply. Without funding, contact tracing cannot scale. Without a vaccine, even good contact tracing faces a pathogen with a 50 percent case fatality rate. The system is not failing at one point — it is failing at every interface between institutions. Kaseya's warning that this could become "the worst Ebola outbreak that the world will have" is not hyperbole calibrated to extract attention. The 2014-2016 West African epidemic infected 28,600 and killed 11,000. At the current trajectory — 11,200 cases in six months with accelerating geographic spread — those numbers are reachable within the next year. The difference between a catastrophe and a controlled decline now rests on whether vaccine trials deliver results, whether the remaining $1.6 billion materialises, and whether DRC's fractured health system can operationalise both before the outbreak reaches population centres it has not yet touched.
Worth reading?
SKIP
Score
20
/100
Extractive. The populations bearing the highest mortality costs have the least access to treatment, funding, or vaccines. Donor pledges function as announcements rather than deployments, concentrating political goodwill at the pledging stage while communities absorb the cost of delayed disbursement.
What Is GRIN?
GRIN stands for Generativity, Resilience, Innovation efficiency, and Novelty openness. These four dimensions capture the essential characteristics of any memetic intelligence — whether a nation, a corporation, a religion, or a movement.
About GRINGenerativity
1/5
Resilience
1/5
Efficiency
1/5
Novelty
1/5
Extractive
4/5
Inverted
Does this create new capability or just redistribute existing value?
Near-zero generativity. No new health capacity is being created. Vaccine trials may yield a tool by 2027, but current response is consuming resources without building durable systems.
Verified Facts (9)
Outbreak announced May 15; more than 11,200 cases and 5,500 deaths recorded per government data.
Over 80 percent of new cases emerge outside contact lists; over 65 percent of deaths occur in the community outside health centres.
Only $1.3bn of the $2.9bn pledged by donors has been released.
Caused by the rare Bundibugyo strain; no vaccine or treatment developed specifically for this strain.
Second-largest and second-deadliest Ebola outbreak on record, behind the 2014-2016 West African outbreak (28,600 infected, 11,000 killed).
Eight of the DRC's 26 provinces affected; cases reported in East, Central, and West Africa.
WHO approved clinical trials of two new Ebola vaccines; results expected early 2027.
At least 3,000 people have recovered from Ebola virus disease in DRC.
Jean Kaseya, director-general of Africa CDC, described coordination as 'a collective failure' and said health workers 'hadn't been paid for months.'
More latest news
Read all